VVEO3 Stock Overview
CM Hospitalar S/A engages in the distribution of hospital materials and medicines in Brazil.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
+ 1 more risk
CM Hospitalar S/A Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$5.44 |
| 52 Week High | R$22.61 |
| 52 Week Low | R$5.39 |
| Beta | 0.37 |
| 1 Month Change | -15.66% |
| 3 Month Change | -51.64% |
| 1 Year Change | -65.74% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -75.05% |
Recent News & Updates
CM Hospitalar S/A (BVMF:VVEO3) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 01
Analysts Are Updating Their CM Hospitalar S/A (BVMF:VVEO3) Estimates After Its Annual Results
Mar 29Why Investors Shouldn't Be Surprised By CM Hospitalar S/A's (BVMF:VVEO3) 28% Share Price Plunge
Mar 27Recent updates
CM Hospitalar S/A (BVMF:VVEO3) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 01Analysts Are Updating Their CM Hospitalar S/A (BVMF:VVEO3) Estimates After Its Annual Results
Mar 29Why Investors Shouldn't Be Surprised By CM Hospitalar S/A's (BVMF:VVEO3) 28% Share Price Plunge
Mar 27Here's Why CM Hospitalar S/A (BVMF:VVEO3) Has A Meaningful Debt Burden
Jan 15Here's What To Make Of CM Hospitalar S/A's (BVMF:VVEO3) Decelerating Rates Of Return
Dec 14CM Hospitalar S/A (BVMF:VVEO3) Has More To Do To Multiply In Value Going Forward
Jun 07Returns On Capital Signal Tricky Times Ahead For CM Hospitalar S/A (BVMF:VVEO3)
Jan 16Be Wary Of CM Hospitalar S/A (BVMF:VVEO3) And Its Returns On Capital
Aug 31Statutory Earnings May Not Be The Best Way To Understand CM Hospitalar S/A's (BVMF:VVEO3) True Position
May 17Pinning Down CM Hospitalar S/A's (BVMF:VVEO3) P/E Is Difficult Right Now
Dec 09Shareholder Returns
| VVEO3 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | -14.2% | 1.8% | -0.2% |
| 1Y | -65.7% | 1.8% | 13.7% |
Return vs Industry: VVEO3 underperformed the BR Healthcare industry which returned 3.9% over the past year.
Return vs Market: VVEO3 underperformed the BR Market which returned 13.9% over the past year.
Price Volatility
| VVEO3 volatility | |
|---|---|
| VVEO3 Average Weekly Movement | 8.9% |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in BR Market | 8.8% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: VVEO3's share price has been volatile over the past 3 months.
Volatility Over Time: VVEO3's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of BR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 6,000 | n/a | portal.mafrahospitalar.com.br |
CM Hospitalar S/A engages in the distribution of hospital materials and medicines in Brazil. It offers cardiac, surgical, urinary, diagnosis, sterilization, wound management, hygiene and protection, infusional, clinical nutrition, orthopedics, and respiratory materials; and medicines that comprise painkillers, anesthetics, anti-allergic products, antibiotics, antiemetics, antifungals, anti-inflammatory products, special control products, miscellaneous products, and oncology products. The company was founded in 1996 and is headquartered in Ribeirão Preto, Brazil.
CM Hospitalar S/A Fundamentals Summary
| VVEO3 fundamental statistics | |
|---|---|
| Market cap | R$1.74b |
| Earnings (TTM) | R$359.92m |
| Revenue (TTM) | R$11.08b |
4.8x
P/E Ratio0.2x
P/S RatioIs VVEO3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VVEO3 income statement (TTM) | |
|---|---|
| Revenue | R$11.08b |
| Cost of Revenue | R$9.35b |
| Gross Profit | R$1.73b |
| Other Expenses | R$1.37b |
| Earnings | R$359.92m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.12 |
| Gross Margin | 15.65% |
| Net Profit Margin | 3.25% |
| Debt/Equity Ratio | 98.1% |
How did VVEO3 perform over the long term?
See historical performance and comparison